Urotensin-II-Targeted Liposomes as a New Drug Delivery System towards Prostate and Colon Cancer Cells

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr class="thead"><td class="align_left">Formulation</td><td class="align_center">Diameter (nm ± SD)</td><td class="align_center">PI ± SD</td><td class="align_center"><i>ζ</i> (mV ± SD)</td><td class="align_center">UT-II on the surface of liposomes (%)</td></tr><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr><td class="align_left">Lipo</td><td class="align_center">147.8 ± 6.90</td><td class="align_center">0.098 ± 0.03</td><td class="align_center">−19.58 ± 5.90</td><td class="align_center">—</td></tr><tr><td class="align_left">LipoUT</td><td class="align_center">168.4 + 9.55</td><td class="align_center">0.203 + 0.07</td><td class="align_center">−26.10 + 4.34</td><td class="align_center">61%</td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Mean diameter, PI, and zeta potential (<i>ζ</i>) of plain liposomes (Lipo) and liposomes conjugated with UT-II (LipoUT).</div>

Journal of Oncology

tab1

Table 1

Table 1: Urotensin-II-Targeted Liposomes as a New Drug Delivery System towards Prostate and Colon Cancer Cells 